Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects

• Auteurs principaux: Maria Isabel Ramos Saraiva (Auteur), Larissa Karine Leite Portocarrero (Auteur), Marcella Amaral Horta Barbosa Vieira (Auteur), Bethania Cabral Cavalli Swiczar (Auteur), Andrezza Telles Westin (Auteur)
• Format: Livre
• Publié: Sociedade Brasileira de Dermatologia, 2018-08-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract: Background: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil...